Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective This study examined the association between vitamin D and metabolic syndrome in patients with psychotic disorders. Methods The study enrolled 302 community-dwelling patients with psychotic disorders. Sociodemographic and clinical characteristics, including blood pressure, physical activity, and dietary habit were gathered. Laboratory examinations included vitamin D, lipid profile, fasting plasma glucose, HbA1c, liver function, and renal function. Vitamin D insufficiency was defined as <20 ng/mL. Clinical characteristics associated with vitamin D insufficiency were identified. Results Among the 302 participants, 236 patients (78.1%) had a vitamin D insufficiency and 97 (32.1%) had metabolic syndrome. Vitamin D insufficiency was significantly associated with the presence of metabolic syndrome (p=0.006) and hypertension (p=0.017). Significant increases in triglycerides and alanine transaminase were observed in the group with a vitamin D insufficiency (p=0.002 and 0.011, respectively). After adjusting for physical activity and dietary habit scores, vitamin D insufficiency remained significantly associated with metabolic syndrome and hypertension. Conclusion Vitamin D insufficiency was associated with metabolic syndrome and was particularly associated with high blood pressure, although the nature, direction and implications of this association are unclear.
Abstract
Objective This study examined the association between vitamin D and metabolic syndrome in patients with psychotic disorders. Methods The study enrolled 302 community-dwelling patients with psychotic disorders. Sociodemographic and clinical characteristics, including blood pressure, physical activity, and dietary habit were gathered. Laboratory examinations included vitamin D, lipid profile, fasting plasma glucose, HbA1c, liver function, and renal function. Vitamin D insufficiency was defined as <20 ng/mL. Clinical characteristics associated with vitamin D insufficiency were identified. Results Among the 302 participants, 236 patients (78.1%) had a vitamin D insufficiency and 97 (32.1%) had metabolic syndrome. Vitamin D insufficiency was significantly associated with the presence of metabolic syndrome (p=0.006) and hypertension (p=0.017). Significant increases in triglycerides and alanine transaminase were observed in the group with a vitamin D insufficiency (p=0.002 and 0.011, respectively). After adjusting for physical activity and dietary habit scores, vitamin D insufficiency remained significantly associated with metabolic syndrome and hypertension. Conclusion Vitamin D insufficiency was associated with metabolic syndrome and was particularly associated with high blood pressure, although the nature, direction and implications of this association are unclear.
참고문헌 (54)
- Wilkins CH, "Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults", Am J Geriatr Psychiatry, 14, pp.1032~1040 (2006)[DOI]
- Endres D, "Vitamin D deficiency in adult patients with schizophreniform and autism spectrum syndromes: a one-year cohort study at a German tertiary care hospital", Front Psychiatry, 7, pp.168~ (2016)
- Berk M, "Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample", Aust N Z J Psychiatry, 42, pp.874~878 (2008)[DOI]
- Berk M, "Vitamin D deficiency may play a role in depression", Med Hypotheses, 69, pp.1316~1319 (2007)[DOI]
- Shukurova M, "Vitamin D level in schizophrenia and association with metabolic syndrome parameters", Klinik Psikofarmakol Bulteni, 25(Suppl 1), pp.S29~S30 (2015)
- Dogan Bulut S, "The relationship between symptom severity and low vitamin D levels in patients with schizophrenia", PLoS One, 11, pp.e0165284~ (2016)[DOI]
- Liu NH, "Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas", World Psychiatry, 16, pp.30~40 (2017)[DOI]
- McGrath JJ, "Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study", Arch Gen Psychiatry, 67, pp.889~894 (2010)[DOI]
- Melamed ML, "25-hydroxyvitamin D levels and the risk of mortality in the general population", Arch Intern Med, 168, pp.1629~1637 (2008)[DOI]
- Wang TJ, "Vitamin D deficiency and risk of cardiovascular disease", Circulation, 117, pp.503~511 (2008)[DOI]
- Giovannucci E, "25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study", Arch Intern Med, 168, pp.1174~1180 (2008)[DOI]
- Martens PJ, "Where and how people with schizophrenia die: a population-based, matched cohort study in Manitoba, Canada", J Clin Psychiatry, 74, pp.e551~e557 (2013)[DOI]
- Sugai T, "High prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus in Japanese outpatients with schizophrenia: a nationwide survey", PLoS one, 11, pp.e0166429~ (2016)[DOI]
- Dawson-Hughes B, "Racial", ethnic considerations in making recommendations for vitamin D for adult and elderly men and women, 2004, pp.80(6 Suppl), 1763S~1766S
- Lips P, "Vitamin D status and nutrition in Europe and Asia", J Steroid Biochem Mol Biol, 103, pp.620~625 (2007)[DOI]
- Lips P, "The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation", J Intern Med, 260, pp.245~254 (2006)[DOI]
- Mithal A, "Global vitamin D status and determinants of hypovitaminosis D", Osteoporos Int, 20, pp.1807~1820 (2009)[DOI]
- Leucht S, "Dose equivalents for antipsychotic drugs: the DDD method", Schizophr Bull, 42(Suppl 1), pp.S90~S94 (2016)[DOI]
- Haro JM, "The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia", Acta Psychiatr Scand Suppl, (406), pp.16~23 (2003)
- Radloff LS, "The CES-D scale: a self-report depression scale for research in the general population", Appl Psychol Meas, 1, pp.385~401 (1977)[DOI]
- Biernat E, "Assessment of physical activity by applying IPAQ questionnaire", J Phys Educ, 52, pp.46~52 (2008)
- [URL]
- Korean Ministry of Health and Welfare, "Dietary Guidelines for Korean Adults", Ministry of Health and Welfare, ~ (2010)
- Lee SY, "Appropriate waist circumference cutoff points for central obesity in Korean adults", Diabetes Res Clin Pract, 75, pp.72~80 (2007)[DOI]
- Pearce SH, "Diagnosis and management of vitamin D deficiency", BMJ, 340, pp.b5664~ (2010)[DOI]
- McGrath JJ, "Vitamin D and mental health-the scrutiny of science delivers a sober message", Acta Psychiatr Scand, 135, pp.183~184 (2017)[DOI]
- Menkes DB, "Vitamin D status of psychiatric inpatients in New Zealand's Waikato region", BMC Psychiatry, 12, pp.68~ (2012)[DOI]
- 나은희, "한국인에서 비타민 D: 성별, 연령, 거주지, 계절에 따른 상태 및 결핍의 유병률", Laboratory Medicine Online, 5(2), pp.84~91 (2015), 대한진단검사의학회
- Lim S, "Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007", Diabetes Care, 34, pp.1323~1328 (2011)[DOI]
- Tran BT, "The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008-2013", BMC Public Health, 17, pp.71~ (2017)[DOI]
- Galassi A, "Metabolic syndrome and risk of cardiovascular disease: a meta-analysis", Am J Med, 119, pp.812~819 (2006)[DOI]
- Hennekens CH, "Schizophrenia and increased risks of cardiovascular disease", Am Heart J, 150, pp.1115~1121 (2005)[DOI]
- Parker J, "Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis", Maturitas, 65, pp.225~236 (2010)[DOI]
- Ford ES, "Concentrations of serum vitamin D and the metabolic syndrome among US adults", Diabetes Care, 28, pp.1228~1230 (2005)[DOI]
- Al-Dabhani K, "Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population", Nutr Diabetes, 7, pp.e263~ (2017)[DOI]
- Wortsman J, "Decreased bioavailability of vitamin D in obesity", Am J Clin Nutr, 72, pp.690~693 (2000)[DOI]
- Awad AB, "Vitamin D and Metabolic syndrome risk factors: evidence and mechanisms", Crit Rev Food Sci Nutr, 52, pp.103~112 (2012)[DOI]
- Li YC, "1, 25-Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin-angiotensin system", J Clin Invest, 110, pp.229~238 (2002)[DOI]
- Mathieu C, "Vitamin D and diabetes", Diabetologia, 48, pp.1247~1257 (2005)[DOI]
- Norman AW, "Vitamin D deficiency inhibits pancreatic secretion of insulin", Science, 209, pp.823~825 (1980)[DOI]
- Tishkoff DX, "Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility", Endocrinology, 149, pp.558~564 (2008)[DOI]
- Artaza JN, "Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells", J Endocrinol, 200, pp.207~221 (2009)
- Sugden J, "Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels", Diabet Med, 25, pp.320~325 (2008)[DOI]
- Bauman A, "The International Prevalence Study on Physical Activity: results from 20 countries", Int J Behav Nutr Phys Act, 6, pp.21~ (2009)[DOI]
- Vancampfort D, "A systematic review of correlates of physical activity in patients with schizophrenia", Acta Psychiatr Scand, 125, pp.352~362 (2012)[DOI]
- Hanley AJ, "Liver markers and development of the metabolic syndrome", Diabetes, 54, pp.3140~3147 (2005)[DOI]
- Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)[DOI]
- Seppala-Lindroos A, "Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men", J Clin Endocrinol Metab, 87, pp.3023~3028 (2002)[DOI]
- Bugianesi E, "Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms", Diabetologia, 48, pp.634~642 (2005)[DOI]
- LaCroix AZ, "Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial", J Gerontol A Biol Sci Med Sci, 64, pp.559~567 (2009)
- Trivedi DP, "Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial", BMJ, 326, pp.469~ (2003)[DOI]
- Sanders KM, "Annual high-dose vitamin D3 and mental well-being: randomised controlled trial", Br J Psychiatry, 198, pp.357~364 (2011)[DOI]
- Anglin RE, "Vitamin D deficiency and depression in adults: systematic review and meta-analysis", Br J Psychiatry, 202, pp.100~107 (2013)[DOI]
- Klingberg E, "Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort", Endocrine, 49, pp.800~808 (2015)[DOI]